期刊文献+

胡晓梅中西医结合治疗骨髓增殖性肿瘤经验 被引量:8

Experience of TCM Physician HU Xiao-mei in Treating Myeloproliferative Neoplasm Through Integrated Traditional Chinese and Western Medicine
下载PDF
导出
摘要 骨髓增殖性肿瘤(MPN)是一类造血干细胞异常克隆增殖性疾病,以真性红细胞增多症(PV)、原发性血小板增多症(ET)和骨髓纤维化(MF)最常见[1-2].近年研究[3]发现,JAK-2/V617F、CALR、MPL等基因突变与MPN预后密切相关.目前,我国临床用药仍较单一,多局限于传统治疗方法如羟基脲、干扰素等,或联合抗血栓治疗,而JAK抑制剂、端粒酶抑制剂。
出处 《浙江中西医结合杂志》 2018年第11期899-901,共3页 Zhejiang Journal of Integrated Traditional Chinese and Western Medicine
  • 相关文献

参考文献5

二级参考文献121

  • 1宋艳秋,王畅,杨芳,王冠军.血小板增多症合并出血的治疗[J].吉林医学,2004,25(10):10-11. 被引量:1
  • 2国家中医药管理局发布.中医病证分类编码[M].武汉:湖北科学技术出版社,1993:23-29.
  • 3中华人民共和国中医药行业标准·中医病证诊断疗效标准(简称国标)[M].南京:南京大学出版社.1994:1-31.
  • 4Spivak JL. Narrative review: thrombocytosis, polycythemia vera, and JAK2 mutations: the phenotypic mimicry of chronic myeloproliferation. Ann Intern Med, 2010 ; 152 ( 5 ) :300 - 306.
  • 5Levine RL, Gilliland DG. Myeloproliferative disorders. Blood, 2008;112(6) : 2190 -2198.
  • 6Molitemo AR, Williams DM, Rogers O, et al. Molecular mimicry in the chronic myeloproliferative disorders: reciprocity between quantitative JAK2 V617F and Mpl expression. Blood, 2006 ; 108 ( 12 ) :3913 - 3915.
  • 7Delhommeau F, Dupont S, Della Valle V, et al. Mutation in TET2 in myeloid cancers. N Engl J Med, 2009 ; 360 ( 22 ) : 2289 - 2301.
  • 8Campbell PJ. Somatic and germline genetics at the JAK2 locus. Nat Genet, 2009; 41 (4) :385 -386.
  • 9Tiedt R, Hao-Shen H, Sobas MA, et al. Ratio of mutant JAK2- V617F to wild-type jak2 determines the MPD phenotypes in transgenic mice. Blood, 2008 ; 111 ( 8 ) : 3931 - 3940.
  • 10Vannucchi AM, Antonioli E, Guglielmelli P, et al. Prospective identification of high-risk polycythemia vera patients based on JAK2 (V617F) allele burden. Leukemia, 2007 ;21 (9) : 1952 - 1959.

共引文献243

同被引文献135

引证文献8

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部